Skip to main content

Show — Main navigation Hide — Main navigation

Home
About
Approach
News
- News
- Newsletter Archive
Reports
Publication Day
Evidence
- Evidence
- Hearings Archive
Compensation
Support

Search

Accessibility Tool

Zoom in
Zoom out
Reset
Contrast
Accessibility tool

Breadcrumb

Home
Evidence
INQY0000312 - Appendix to the Presentation note on the response to risk by pharmaceutical companies involved in blood products; November 2021

INQY0000312 - Appendix to the Presentation note on the response to risk by pharmaceutical companies involved in blood products; November 2021

Documents

2 November 2021

INQY0000312 Appendix to Presentation note on the response to risk by pharmaceutical companies Nov 2021

pdf

(1.05 MB)

Download

Evidence Information

Date

2 November 2021

Witness

Presentation on Pharmaceutical companies' response to risk

View other evidence

Related Content

INQY0000311 - Presentation note on the response to risk by pharmaceutical companies involved in blood products; November 2021

Inquiry

Home
About
Approach
Participate
News
Evidence
Support
Get in touch

Legal

Terms & Conditions
Cookies notice
Privacy Notice
Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN

Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.